ASND News and Press, Ascendis Pharma A/S From 02/10/26

2026-02-10 17:35:51 ET More on Ascendis Pharma Ascendis: Why I'm Skeptical On Takeover Rumors, Long-Term Targets Ascendis Pharma A/S (ASND) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Resul...

COPENHAGEN, Denmark, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report full year 2025 financial results and provide a business update on Wednesday, February 11, 2026, after the close of the U.S. financial markets. Ascendis Pharma also plans to...

2026-02-03 10:31:10 ET The Liberty All-Star Growth Fund ( ASG ) is a closed-end equity fund that investors in search of income may wish to purchase as a means of generating a high level of current income without the need to sacrifice their equity exposure.... Read the full art...

2026-01-25 22:39:50 ET Investment Overview The stock of Ascendis Pharma ( ASND ) has risen in value by >1,000% over the past decade, climbing from a price of ~$20, to >$235 per share at the time of writing. Stock is also up >85% on a 1-year basis.... Read the full...

2026-01-25 22:39:50 ET Investment Overview The stock of Ascendis Pharma ( ASND ) has risen in value by >1,000% over the past decade, climbing from a price of ~$20 to >$235 per share at the time of writing. Stock is also up >85% on a 1-year basis.... Read the full ...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.0% to $2.0582 on volume of 396,224,419 shares Intel Corporation (INTC) fell 17.7% to $44.73 on volume of 245,750,101 shares SCWorx Corp. (WORX) rose 37.3% to $0.2501 on volume of...

2026-01-22 11:47:47 ET More on Ascendis Pharma Ascendis Pharma A/S (ASND) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondro...

2026-01-20 08:05:14 ET from RBC Capital issued a price target of $250.00 for ASND on 2026-01-20 12:44:33. The adjusted price target was set to $250.00. At the time of the announcement, ASND was trading at $205.83. The overall price target consensus is at $267.50 with hig...

2026-01-12 15:46:02 ET Ascendis Pharma A/S (ASND) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 10:30 AM EST... Read the full article on Seeking Alpha For further details see: Ascendis Pharma A/S (ASND) Presents at 44th Annual J.P. Morgan Healthcare Conferen...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones. Ascendis President and CEO Jan Mikkelsen will present this update on Monday, January 12, during the 44...